期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
抗病毒治疗慢性乙型肝炎患者血清外泌体HBV-miR-3动态变化与病毒学指标的关系
1
作者 钟剑秋 徐燕 徐敏 《肝脏》 2023年第9期1044-1047,共4页
目的探讨抗病毒治疗慢性乙型肝炎(CHB)患者血清外泌体HBV-miR-3动态变化与病毒学指标的关系。方法选取2020年6月至2021年6月收治的116例CHB患者,均接受抗病毒治疗12个月,比较发生病毒学应答组(VR+组)和未发生病毒学应答组(VR-组)一般资... 目的探讨抗病毒治疗慢性乙型肝炎(CHB)患者血清外泌体HBV-miR-3动态变化与病毒学指标的关系。方法选取2020年6月至2021年6月收治的116例CHB患者,均接受抗病毒治疗12个月,比较发生病毒学应答组(VR+组)和未发生病毒学应答组(VR-组)一般资料及接受抗病毒治疗前后病毒学指标和外泌体HBV-miR-3的动态变化。采用Pearson相关分析外泌体HBV-miR-3水平与病毒学指标的关系,采用受试者工作特征曲线分析外泌体HBV-miR-3水平对病毒学应答的预测效能。结果经12个月抗病毒治疗后,VR+组54例,VR-组62例,病毒学应答率为46.55%;VR+组ALT水平高于VR-组,而HBsAg、HBV DNA和外泌体HBV-miR-3水平低于VR-组(P<0.05);VR+组HBsAg、HBV DNA和外泌体HBV-miR-3水平在接受抗病毒治疗后明显下降,而VR-组虽有下降但变化不明显,且一直高于VR+组(P<0.05);血清外泌体HBV-miR-3水平与ALT无明显相关性(r=0.049,P=0.241),与HBV DNA和HBsAg呈正相关(r=0.314、0.809,P<0.05)。治疗3个月时,以4.52lg拷贝/mL为最佳界值的AUC最大为0.857(95%CI:0.716~0.962),敏感度和特异度最高,分别为82.70%和78.10%。结论CHB患者血清外泌体HBV-miR-3水平随着抗病毒治疗时间的延长而下降,与病毒学指标HBV DNA和HBsAg呈正相关,抗病毒治疗3个月时HBV-miR-3的临界值可作为预测CHB患者抗病毒治疗12个月的病毒学应答的指标。 展开更多
关键词 抗病毒治疗 慢性乙型肝炎 外泌体hbv-mir-3 病毒学指标
下载PDF
An HBV-encoded miRNA activates innate immunity to restrict HBV replication 被引量:20
2
作者 Xiaoqing Zhao Lu Sun +5 位作者 Ting Mu Jianying Yi Chaoqun Ma Hong Xie Min Liu Hua Tang 《Journal of Molecular Cell Biology》 SCIE CAS CSCD 2020年第4期263-276,共14页
We previously identified that hepatitis B virus(HBV)encodes a microRNA(HBV-miR-3)that restrains HBV replication by targeting the HBV transcript.However,whether HBV-miR-3 affects host innate immunity to modulate HBV re... We previously identified that hepatitis B virus(HBV)encodes a microRNA(HBV-miR-3)that restrains HBV replication by targeting the HBV transcript.However,whether HBV-miR-3 affects host innate immunity to modulate HBV replication remains unclear.Here,we examined the vital functions of HBV-miR-3 in the innate immune response after HBV infection.We found that HBV-miR-3 expression gradually increased in a dose-and time-dependent manner in HBV-infected HepG2-NTCP cells.HBV-miR-3 activated the JAK/STAT signaling pathway by downregulating SOCS5 in hepatocytes,thereby enhancing the IFN-induced anti-HBV effect.In addition,HBVmiR-3 in exosomes facilitated the Ml polarization of macrophages.Furthermore,exosomes containing HBV-miR-3 enhanced the secretion of IL-6 via inhibiting the SOCS5-mediated ubiquitination of EGFR.In short,these results demonstrate that HBV-miR-3 activates the innate immune response to restrain HBV replication by multiple pathways,which may suppress HBV-induced acute liver cell injury and affect the progression of persistent HBV infection. 展开更多
关键词 hepatitis B virus hbv-mir-3 IFN M1 polarization IL-6
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部